The granin family of uniquely acidic proteins of the diffuse neuroendocrine system: Comparative and functional aspects

Biological Reviews of the Cambridge Philosophical Society

Volumn 79, Issue 4, 2004, Pages 769-794

  Helle, Karen B ^a  

^a UNIVERSITY OF BERGEN   (Norway)

Author keywords

Catestatin; CgA; CgB; Pancreastatin; Parastatin; Regulatory peptides; Secretolytin; Secretoneurin; SgII; Vasostatins

Indexed keywords

AMINO ACID DERIVATIVE; CATESTATIN; CHROMACIN; CHROMOGRANIN; CHROMOGRANIN A; CHROMOGRANIN B; CHROMOGRANIN DERIVATIVE; FURIN; PANCREASTATIN; PARASTATIN; PROHORMONE CONVERTING ENZYME PC1; PROHORMONE CONVERTING ENZYME PC2; PROHORMONE CONVERTING ENZYME PC3; REGULATOR PROTEIN; SECRETOGRANIN II; SECRETOGRANIN III; SECRETOGRANIN IV; SECRETOGRANIN V; SECRETOGRANIN VI; SECRETOGRANIN VII; SECRETOLYTIN; SECRETONEURIN; SECRETORY PROTEIN; UNCLASSIFIED DRUG; VASOSTATIN DERIVATIVE; WE 14;

AUTOCRINE EFFECT; BASE PAIRING; BINDING SITE; CELL GRANULE; CELL INTERACTION; CELL REGENERATION; COMPARATIVE ANATOMY; ENDOCRINE CELL; FUNCTIONAL ANATOMY; GENETIC ANALYSIS; HOMEOSTASIS; HOST RESISTANCE; HUMAN; INFLAMMATION; NEUROENDOCRINE SYSTEM; NONHUMAN; NUCLEOTIDE SEQUENCE; PARACRINE SIGNALING; PHYLOGENY; PROTEIN ASSEMBLY; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN STRUCTURE; REVIEW;

ANIMALS; CHROMOGRANINS; EVOLUTION, MOLECULAR; HUMANS; NEUROSECRETORY SYSTEMS; PHYLOGENY; PROTEINS;

EID: 9644276789     PISSN: 14647931     EISSN: None     Source Type: Journal    
DOI: 10.1017/S146479310400644X     Document Type: Review

References (237)

1. AARDAL, S. & HELLE, K. B. (1992). The vasoinhibitory activity of bovine chromogranin A fragments (vasostatins) and its independence of extracellular calcium in isolated segments of human blood vessels. Regulatory Peptides 41, 9-18.
2. AARDAL, S., HELLE, K. B., ELSAYED, S., REED, R. K. & SERCK-HANSSEN, G. (1993). Vasostatins, comprising the N-terminal domains of chromogranin A, suppress tension in isolated human blood vessel segments. Journal of Neuroendocrinology 5, 105-112.
3. AMORAL, S., AARDAL, N. P., LARSEN, T. H., ANGELETTI, R. H., STRIDSBERG, M., TAUPENOT, L., AUNIS, D. & HELLE, K. B. (1996). Human pheochromocytoma: different patterns of catecholamines and chromogranins in the intact tumor, urine and serum in clinically unsuspected cases. Journal of Clinical and Laboratory Investigations 56, 511-523.
4. AMATORE, C., BOURET, Y., TRAVIS, E. R. & WIGHTMAN, R. M. (2000). Interplay between membrane dynamics, diffusion and swelling pressure governs individual vesicular exocytosis events during release of adrenaline from chromaffin cells. Biochimie 82, 481-496.
5. ANGELETTI, R. H., AARDAL, S., SERCK-HANSSEN, G., GEE, P. & HELLE, K. B. (1994). Vasoinhibitory activity of the synthetic peptides from the amino terminus of the adrenomedullary chromogranin A. Acta Physiologica Scandinavica 152, 11-19.
6. ANGELETTI, R. H., D'AMICO, T. D. & RUSSELL, J. (2000). Regulation of parathyroid secretion. Chromogranins, chemokines and calcium. Advances in Experimental Medicine & Biology 482, 217-223.
7. ANGELETTI, R. H., MINTS, L., ABER, C. & RUSSELL, J. (1996). Determination of residues in chromogranin A (16-40) required for inhibition of parathyroid hormone secretion. Endocrinology 137, 2918-2922.
8. ANGELONE, T., DE IURI, E., CORTI, A., TOTA, B. & CERRA, M. C. (2003). Cardiosuppressive action of vasostatins on the Langendorff isolated and perfused rat heart. Proceedings of the 12th International symposium on chromaffin cell biology, 21-25 September 2003, Abstract.
9. ARVAN, P. & CASTLE, D. (1998). Sorting and storage during secretory granule biogenesis: looking backward and looking forward. Biochemical Journal 332, 593-610.
10. BANKS, P, & HELLE, K. B. (1965). The release of protein from the stimulated adrenal medulla. Biochemical Journal 97, 40C-41C.
11. BARKATULLAH, S. C., CURRY, W. J., JOHNSTON, C. F. & BUCHANAN, K. D. (1997). The distribution of WE-14 in the invertebrate and vertebrate nervous system. Regulatory Peptides 71, P47.
12. BARRENECHEA, M. A., LOPEZ, J. & MARTINEZ, A. (1994). Regulatory peptides in gastric endocrine cells of the rainbow trout Onchorhynchus mykis: general distribution and colocalization. Tissue & Cell 26, 309-321.
13. BAUER, J. W. & FISCHER-COLBRIE, R. (1991). Primary structure of bovine chromogranin B deduced from cDNA sequence. Biochimica Biophysica Acta 1089, 124-126.
14. BENEDUM, U. M., BAEUERLE, P. A., KONECKI, D. S., FRANK R., POWELL, J., MALLET, J. & HUTTNER, W. B. (1986). The primary structure of bovine chromogranin A: a representative for a class of acidic secretory proteins common to a variety of peptidergic cells. EMBO Journal 5, 1495-1502.
15. BENEDUM, U. M., LAMOUROUX, A., KONECKI, D. S., ROSA, P., HILLE, A., BAEUERLE, P. A., FRANK, R., LOTTSPEICH, F., MALLET, J. & HUTTNER, W. B. (1987). The primary structure of human secretogranin I (chromogranin B): comparison with chromogranin A reveals homologous terminal domains and a large intervening variable region. EMBO Journal 6, 203-1211.
16. BENJANNET, S., LEDUC, R., ADROUCHE, N., FALGUEYRET, J. P., MARCINKIEWICZ, M., SEIDAH, N. G., MBIKAY, M., LAZURE, C. & CHRETIEN, M. (1987). Chromogranin B (secretogranin I), a putative precursor of two novel pituitary peptides through processing at paired basic residues. FEBS Letters 224, 142-148.
17. BENENNET, S., RONDEAU, N., DAY, R., CHRETIEN, M. & SEIDAH, N. G. (1993), Comparative biosynthesis, covalent post-translational modifications and efficiency of prosegment cleavage of the prohormone convertases PC1 and PC2: glycosylation, sulphation and identification of the intracellular site of prosegment cleavage of PC1 and PC2. Biochemical Journal 294, 735-743.
18. BERGENFELZ, A., LUTS, L., BORGLUM JENSEN, T. & SUNDLER, F. (2000). Pancreastatin plasma levels in patients with primary hyperparathyroidism. World Journal of Surgery 24, 1579-1583.
19. BLAVSCHKO, H., COMLINE, R. S., SCHNEIDER, F. H., SILVER, M. & SMITH, A. D. (1967). Secretion of a chromaffin granule protein, chromogranin, from the adrenal gland after splanchnic stimulation. Nature 215, 58-59.
20. BLAZQUEZ, M., BOSMA, P. T., CHANG, J. P., DOCHERTY, K. & TRUDEAU, V. L. (1998). γ-Aminobutyric acid up-regulates the expression of a novel secretogranin II messenger ribonucleic acid in the goldfish pituitary. Endocrinology 139, 4870-4880.
21. BORGES, R., MACHADO, J. D., ALONSO, C., BRIOSO, M. A. & GOMEZ, J. F. (2000). Functional role of chromogranins. The intragranular matrix in the last phase of exocytosis. Advances in Experimental Medicine & Biology 482, 69-81.
22. BRAKS, J. A. & MARTENS, G. J. (1994). 7B2 is a neuroendocrine chaperone that transiently interacts with prohormone convertase PC2 in the secretory pathway. Cell 78, 263-273.
23. BREKKE, J. F., KIRKELEIT, J., LUGARDON, K. & HELLE, K. B. (2000). Vasostatins. Dilators of bovine resistance arteries. Advances in Experimental Medicine and Biology 482, 239-246.
24. BREKKE, J. F., OSOL, G. J. & HELLE, K. B. (2002). N-terminal chromogranin-derived peptides as dilators of bovine coronary resistance arteries. Regulatory Peptides 105, 93-100.
25. CAXU, N., POSSENTI, R., RICCO, A. S., ROCCHI, M. & LEVI, A. (1997). Cloning, structural organization analysis and chromosomal assignment of the human gene for the neurosecretory protein VGF. Genomics 45, 443-446.
26. CECONI, C., FERRARI, R., BACHEITI, T., OPASICH, C., VOLTERRANI, M., COLOMBO, B., PARRINELLO, G. & CORTI, A. (2002). Chromogranin A in heart failure; a novel neurohumoral factor and a predictor for mortality. European Heart Journal 23, 967-974.
27. CHANAT, E. & HUTTNER, W. B. (1991). Milieu-induced, selective aggregation of regulated secretory proteins in the trans-Golgi network. Journal of Cell Biology 115, 1505-1519.
28. CHANAT, E., WEISS, U. & HUTTNER, W. B. (1994). The disulfide bond in chromogranin B, which is essential for its sorting to secretory granules, is not required for its aggregation in the trans-Golgi network. FEBS Letters 352, 225-230.
29. CHANAT, E., WEISS, U., HUTTNER, W. B. & TOOZE, S. A. (1993). Reduction of the disulfide bond of chromogranin B (secretogranin I) in the trans-Golgi network causes its missorting to the constitutive pathway. EMBO Journal 12, 2159-2168.
30. ClESlELSKI-TRESKA, J., ULRICH, G., CHASSEROT-GOLAZ, S., ZWILLER, J., REVEL, M. O., AUNIS, D. & BADER, M. F. (2001). Mechanisms underlying neuronal death induced by chromogranin A-activated microglia. Journal of Biological Chemistry 276, 13113-13120.
31. CIESIELSKI-TRESKA, J., ULRICH, G., TAUPENOT, L., GHASSEROT-GOLAZ, S., CORTI, A., AUNIS, D. & BADER, M. F. (1998). Chromogramn A induces a neurotoxic phenotype in brain microglial cells. Journal of Biological Chemistry 273, 14339-14346.
32. COHN, D. V., ZANGERLE, R., FISCHER-COLBRIE, R., CHU, L. L. H., ELTING, J. J., HAMILTON, J. W. & WINKLER, H. (1982). Similarity of secretory protein-I from parathyroid gland to chromogranin A from adrenal medulla. Proceedings of the National Academy of Science, USA 79, 6036-6059.
33. CONLON, J. M., HAMBERGER, B. & GRIMELIUS, L. (1992). Isolation of peptides arising-from the specific posttranslational processing of chromogranin A and chromogranin B from human pheochromocytoma tissues. Peptides 13, 639-644.
34. CORTI, A., MANNARINO, C., MAZZA, R., COLOMBO, B., LONGHI, R. & TOTA, B. (2002). Vasostatins exert negative inotropism in the working heart of the frog. Annals of New York Academy of Sciences 971, 362-365.
35. CORTI, A., SANCHEZ, L. P., GASPARRI, A., CURNIS, F., LONGI, R., BRANDAZZA, A., SICCARDI, A. G. & SIDOI, A. (1997). Production and structure characterization of recombinant chromogranin N-terminal fragments (vasostatins). Evidence for dimer-monomer equilibria. European Journal of Biochemistry 248, 692-699.
36. 2+-binding protein. Cell Biolology International Reports 12, 493.
37. CRYER, P. E., WORTMAN, J., SHA, S. D., NOVAK, R. M. & DEFTOS, L. J. (1991). Plasma chromogranin A as a marker for sympathochromaffin activity in humans. American Journal of Physiology 260, E243-E246.
38. CURRY, W. J., BARKATULLAH, S. C., JOHANSSON, A. N., QUINN, J. G., NORLEN, P., CONNOLLY, C. K., MCCOLLUM, A. P. & MCVICAR, C. M. (2002). WE-14, a chromogranin A-derived neuropeptide. Annals of the New York Academy of Sciences 971, 311-316.
39. CURRY, W. J., JOHNSTON, C. F., HUTTON, J. C., ARDEN, S. N., RUTHERFORD, N. G., SHAW, C. & BUCHANAN, K. D. (1991). The tissue distribution of rat chromogranin A derived peptides: evidence for differential tissue processing from sequence specific antisera. Histochemistry 96, 513-538.
40. CURRY, W. J., JOHNSTON, C. F., SHAW, C. & BUCHANAN, K. D. (1990). Distribution and partial characterization of immunoreactivity to the putative C-terminus of rat pancreastatin. Regulatory Peptides 30, 207-219.
41. CURRY, W. J., MCCOLLUM, A. P., BROCKBANK, S., GARDINER, T. A., MAULE, A. G. & STITT, A. W. (2003). Characterization of WE-14 in porcine ocular tissue. Regulatory Peptides 113, 41-47.
42. CURRY, W. J., SHAW, C., JOHNSTON, C. F., THIM, L. & BUCHANAN, K. D. (1992). Isolation and primary structure of a novel chromogranin A derived peptide, WE-14, from a midgut carcinoid tumor. FEBS Letters 30, 319-321.
43. DEFTOS, L. J., ANGELETTI, R. H., CHALBERG, C. & TU, S. (1989). PTHrP secretion is stimulated by CT and inhibited by CGA peptides. Endocrinology 125, 563-565.
44. DEFTOS, L. J., ANGELETTI, R. H., CHALBERG, C. & TU, S. (1990). A chromogranin A-derived pepride differentially regulates the secretion of calcitonin gene products. Journal of Bone and Mineral Research 5, 989-991.
45. DEFTOS, L. J., BJØRNSSON, B. T., BURTON, D. W., O'CONNOR, D. T. & COPP, D. N. (1987). Chromogranin A is present in and released by fish endocrine tissue. Life Sciences 40, 2133-2136.
46. DOPAZO, A., LOVENBERG, T. W., DANIELSON, P. E., OTTIGER, H. P. & SUTCLIFFE, J. G. (1993). Primary structure of mouse secretogranin III and its absence from deficient mice. Journal of Molecular Neuroscience 4, 225-233.
47. DREES, B. M. & HAMILTON, W. J. (1992). Pancreastatin and bovine parathyroid cell secretion. Bone and Minerals 17, 335-346.
48. DREES, B. M., ROUSE, J., JOHNSON, J. & HAMILTON, J. W. (1991). Bovine parathyroid glands secrete a 26 kDa N-terminal fragment of chromogranin-A which inhibits parathyroid cell secretion. Endocrinology 129, 3381-3387.
49. EIDEN, L. (1987). Is chromogranin A a prohormone? Nature 325, 301.
50. EIDEN, L. E., HUTTNER, W. B., MALLET, J., O'CONNOR, D. T., WINKLER, H. & ZANINI, A. (1987). A nomenclature proposal for the chromogranin/ secretogranin proteins. Neuroscience 21, 1019-1021.
51. ESKELAND, N. L., ZHOU, A., DINH, T. Q. WU, H., PARMER, R. J., MAINS, R. E. & O'CONNOR, D. T. (1996). Chromogranin A processing and secretion: specific role of endogenous and exogenous prohormone convertases in the regulated secretory pathway. Journal of Clinical Investigations 98, 148-156.
52. FALKENSAMER, G., FISCHER-COLBRIE, R., RICHTER, K. & WINKLER, H. (1985). Cell-free and cellular synthesis of chromogranin A and B of bovine adrenal medulla. Neuroscience 14, 735-746.
53. FASCIOTTO, B. H., COHN, C. V. & GORR, S. U. (2002). N-terminal proteolytic processing of porcine chromogranin A in parathyroid tissue. Regulatory Peptides 103, 53-58.
54. FASCIOTTO, B. H., DENNY, J. C., GREELEY, G. H. JR. & COHN, C. V. (2000). Processing of chromogranin A in the parathyroid: generation of parastatin-related peptides. Peptides 21, 1389-1401.
55. FASCIOTTO, B. H., TRAUSS, C. A., GREELEY, G. H. & COHN, D. V. (1993). Parastatin (porcine chromogranin A347-419), a novel chromogranin A-derived peptide, inhibits parathyroid cell secretion. Endocinology 133, 461-466.
56. FELDMAN, S. A. & EIDEN, L. E, (2003). The chromogranins: their roles in secretion from neuroendocrine cells and as markers for neuroendocrine neoplasia. Endocrine Pathology 14, 3-23.
57. FERRERO, E., MAGNI, E., CURNIS, F., VILLA, M. E. & FERRERO, M. E. (2002). Regulation of endothelial cell shape and barrier function by chromogranin A. Annals of the New York Academy of Sciences 971, 355-358.
58. FERRERO, E., SCABINI, S., MAGNI, E., FOGLIENI, C., BELLONI, D., COLOMBO, B., CURNIS, F., VILLA, A., FERRERO, M. E. & CORTI, A. (2004). Chromogranin A protects vessels against tumor necrosis factor alpha-induced vascular leakage. FASEB Journal 18, 554-556.
59. FlSCHER-COLBRIE, R., EDER, S., LOVISETTI-SCAMIHORN, P., BECKER, A. & LASLOP, A. (2002). Neuroendocrine secretory protein 55 a novel marker for the constitutive secretory pathway. Annals of the New York Academy of Sciences 971, 317-322.
60. FISCHER-COLBRIE, R., GUTIERREZ, J., HSU, C. M., IACANGELO, A. & EIDEN, L. E. (1990). Sequence analysis, tissue distribution and regulation by cell depolarization and second messengers of bovine secretogranin II (chromogranin C) mRNA. Journal of Biological Chemistry 265, 9208-9213.
61. FISCHER-COLBRIE, R., LASLOP, A. & KIRCHMAIR, R. (1995). Secretogranin II: molecular properties, regulation of biosynthesis and processing to the neuropeptide secretoneurin. Progress in Neurobiolology 46, 49-70.
62. FISCHER-COLBRIE, R., LASSMANN, H., UAGN, C. & WlNKLER, H. (1985). Immunological studies on the distribution of chromogranin A and B in endocrine and nervous tissue. Neuroscience 16, 547-555.
63. FLANAGAN, T., TAYLOR, L., POULTER, L. VIVEROS, O. H. & DILIBERTO, E. J. JR. (1990). A novel 1745-dalton pyroglutamyl peptide derived from chromogranin B is in the bovine adreno-medullary chromaffin vesicle. Cellular and Molecular Neurobiology 10, 507-523.
64. FORSVTHE, P., CURRY, W. J., JOHNSTON, C. F., HARRIOTT, P., MACMAHON, J. & ENNIS, M. (1997). The modulatory effects of WE-14 on histamine release from rat peritoneal mast cells. Inflammation Research 46 (suppl. 1), S13-S14.
65. GADROV, P., STRIDSBERG, M., CAPON, C., MICHALSKI, J. C., STRUB, J. M., VAN DORSSELAER, A., AUNIS, D. & METZ-BOUTIGUE, M.-H. (1998). Phosphorylation and O-glycosylation sites of human chromogranin A (CGA79-439) from urine of patients with carcinoid tumors. Journal of Biological Chemistry 273, 34087-34097.
66. GASPARRI, A., SIDOLI, A., SANCHEZ, L. P., LONGHI, R., SICGARDI, A. G., MARCHISIO, P. C. & CORTI, A. (1997). Chromogranin A fragments modulate cell adhesion. Identification and characterization of a pro-adhesive domain. Journal of Biological Chemistry 272, 20835-20843.
67. GERDES, H.-H. & GLOMBIK, M. M. (2000). Signal-mediated sorting of chromogranins to secretory granules. Advances in Experimental Medicine and Biology 482, 41-54.
68. GERDES, H.-H., ROSA, P., PHILLIPS, E., BAUERLE, P. A., FRANK, R., ARGOS, P. & HUTTNER, W. B. (1989). The primary structure of human secretogranin II, a widespread tyrosine-sulphated secretory granule protein that exhibits low pH- and calcium-induced aggregation. Journal of Biological Chemistry 264, 12009-12015.
69. GLOMBIK, M. M. & GERDES, H.-H. (2000). Signal-mediated sorting of neuropeptides and prohormones: secretory granule biogenesis revisited. Biochimie 82, 315-326.
70. GLOMBIK, M. M., KRÖMER, A., SALM, T., HUTTNER, W. B. & GERDES, H.-H. (1999). The disulfide-bonded loop of chromogranin B mediates membrane binding and directs sorting from the trans-Golgi network to secretory granules. EMBO Journal 18, 1059-1070.
71. GLEESON, C. M., CURRY, W. J., JOHNSTON, C. F. & BUCHANAN, K. D. (1996). Occurrence of WE-14 and chromogranin A-derived peptides in tissues of the human and bovine gastroentero-pancreatic system and in human neuroendocrine neoplasia. Journal of Endocrinology 151, 409-420.
72. GONG, L.-W., HAFEZ, L, ALVAREZ DE TOLEDO, G. & LINDAU, M. (2003). Secretory vesicle membrane area is regulated in tandem with quantal size in chromaffin cells. The Journal of Neuroscience 23, 7917-7921.
73. GONZALEZ-YANES, C. & SANCHEZ-MARGALET, V. (2000). Pancreastatin modulates insulin signaling in rat adipocytes: mechanisms of cross-talk. Diabetes 49, 1288-1294.
74. GONZALEZ-YANES, C. & SANCHEZ-MARGALET, V. (2002). Pancreastatin, a chromogranin A-derived peptide, activates protein synthesis signaling cascade in rat adipocytes. Biochemical and Biophysical Research Communication 299, 525-531.
75. 2 by interacting with specific receptors in rat heart membranes. Cellular Signalling 13, 43-49.
76. GORR, S.-U., DEAN, W. L., RADLEY, T. L. & COHN, D. V. (1988). Calcium-binding and aggregation properties of parathyroid secretory protein-I (chromogranin A). Bone and Minerals 4, 17-25.
77. GORR, S.-U., SHIOI, J. & COHN. D. V. (1989). Interaction of calcium with porcine chromogranin A (secretory protein-I) and chromogranin B (secretogranin I). American Journal of Physiology 257, 247-254.
78. GRUBE, D., AUNIS, D., BADER, M.-F., CETIN, Y., JØRNS, A. & YOSHIE, S. (1986). Chromogranin A (CgA) in the gastro-enteropancreatic (GEP) endocrine system. Histochemistry 85, 441-452.
79. HAGN, C., SOMID, K. W., FISCHER-COLBRIE, R. & WINKLER, H. (1986). Chromogranin A, B and C in adrenal medulla and endocrine tissues. Laboratory Investigations 55, 405-411.
80. HÅKANSON, R., DING, X. Q., NORLEN, P. & CHEN, D. (1995). Circulating pancreastatin is a marker for the enterochromaffin-like cells of the rat stomach. Gastroenterology 108, 1445-1452.
81. HALBAN, F. & IRMINGER, J. C. (1994). Sorting and processing of secretory proteins. Biochemical Journal 299, 1-18.
82. HELLE, K. B. (1966). Some chemical and physical properties of the soluble fraction of bovine adrenal chromaifin granules. Molecular Pharmacology 2, 298-310.
83. HELLE, K. B. (1973). Formation of in vitro of matrix like aggregates of chromogranins and phospholipids derived from chromaffin granules of the bovine adrenal medulla. Biochimica Biophysica Acta 318, 181-196.
84. HELLE, K. B. (1990). Chromogranins: universal proteins from paramecium to man. Neurochemistry International 17, 165-175.
85. HELLE, K. B. & ANGELETTI, R. H. (1994). Chromogranin A: a multipurpose prohormone? Acta Physiologica Scandinavica 152, 1-10.
86. HELLE, K. B. & AUNIS, D. (2000). A physiological role for the granms as prohormones for homeostatically important regulatory peptides? A working hypothesis for future research. Advances in Experimental Medicine and Biology 482, 389-397.
87. HELLE, K. B., FLATMARK, T., SERCK-HANSSEN, G. & LØNNING, S. (1971). An improved method for the large scale isolation of chromaffin granules from bovine adrenal medulla. Biochimica Biophysica Acta, 226, 1-8.
88. HELLE, K. B., MARLEY, P. D., HOGUE-ANGELETTI, R., GALINDO, E., AUNIS, D., SMALL, D. H. & LIVETT, B. G. (1993). Chromogranin A; secretion of processed products from the stimulated retrogradely perfused bovine adrenal gland. Journal of Neuroendocrinology 5, 413-420.
89. HELLE, K. B., METZ-BOLTIGUE, M. H. & AUNIS, D. (2001). Chromogranin A as a calcium-binding precursor for multiple regulatory peptides for the immune, endocrine and metabolic systems. Current Medicinal Chemistry - Immunological, Endocrine and Metabolic Agents 1, 119-140.
90. HELLE, K. B., REED, R. K., PIHL, K. E. & SERCK-HANSSEN, G. (1985). Osmotic properties of the chromogranins and relation to osmotic pressure in catecholamine storage granules. Acta Physiologica Scandinavica 123, 8-22.
91. HELMAN, L. J., AHN, T. G., LEVINE, M. A., ALLISON, A., COHEN, P. S., COOPER, M. J., COHN, D. V. & ISRAEL, M. A. (1988). Molecular cloning and primary structure of human chromogranin A (secretory protein I) cDNA. Journal of Biological Chemistry 263, 11559-11563.
92. HERRERO, C. J., ALES, E., PINTADO, A. J., LOPEZ, M. G., GARCIA-POMERO, E., MAHATA, S. K., O'CONNOR, D. T., GARCIA, A. G. & MOXTIEL, C. (2002). Modulatory mechanism of the endogenous peptide catetatin on neuronal nicotinic acetylcholine receptors and exocytosis. Journal of Neuroscience 22, 377-388.
93. HOFLEHNER, J., EDER, U., LASLOP, A., SEIDAH, N. G., FISCHER-COLBRIE, R. & WINKLER, H. (1995). Processing of secretogranin II by prohormone convertases: importance of PC 1 in generation of secretoneurin. FEBS Letters 360, 294-298.
94. HOLTHUIS, J. C. & MARTENS, G. J. (1996). The endocrine protein secretogranin II and III are regionally conserved and coordinately expressed with proopiomelanocortin in Xenopus intermediate pituitary. Journal of Neurochemistry 66, 2248-2256.
95. HOSAKA, M., WATANABE, T., SAKAI, Y., UCHIYAMA, Y. & TAKEUCHI, T. (2002). Identification of a chromogranin A domain that mediates binding to secretogranin III and targeting to secretory granules in pituitary and pancreatic β-cells. Molecular Biology of the Cell 13, 3388-3399.
96. HUANG, X. F. & ,ARVAN, P. (1995). Intracellular transport of proinsulin in pancreatic beta cells. Structural maturation probed by disulfide accessibility. Journal of Biological Chemistry 270, 20417-20423.
97. HUTTNER, W. B., GERDES, H.-H. & ROSA, P. (1991a). Chromogranins/secretogranins - widespread constituents of the secretory granule matrix in endocrine cells and neurons. In Markers for neuronal and endocrine cells. Molecular and cell biology diagnostic applications (eds. M. Gratzl and K. Langley), pp. 94-131. VCH Verlagsgesellshaft mbH, Weinheim, Germany.
98. HUTTNER, W. B., GERDES, H.-H. & ROSA, P. (1991b). The granin (chromogranin/secretogranin) family. Trends in Biochemical Sciences 16, 27-31.
99. HUTTNER, W. B. & NATORI, S. (1995). Helper proteins for neuroendocrine secretion. Current Biology 5, 242-245.
100. HUTTON, J. C., NIELSEN, E. & KASTERN, W. (1988). The molecular cloning of the chromogranin A-like precursor of beta-granin and pancreastatin from the endocrine pancreas. FEBS Letters 236, 269-274.
101. HWANG, J. R., SIEKHAUS, D. E., FULLER, R. S., TAGERT, P. H. & LINDBERG, I. (2000). Interaction of Drosophilia melanogaster prohormone convertase 2 and 7B2. Insect cell-specific processing and secretion. Journal of Biological Chemistry 275, 17886-17893.
102. LACANGELO, A., AFFOLTER, H., EIDEN, L., HERBERT, E. & GRIMES, M. (1986). Bovine chromogranin A: its sequence and the distribution of its messenger RNA in tissues. Nature 323, 82-86.
103. IACANGELO, A. & EIDEN, L. E. (1995). Chromogranin A: current status as a precursor for bioactive peptides and a granulogenic/sorting factor in the regulated secretory pathway. Regulatory Peptides 58, 65-88.
104. IACANGELO, A., OKAYAMA, H. & EIDEN, L. E. (1988). Primary structure of rat chromogranin A and distribution of its mRNA. FEBS Letters 227, 115-121.
105. IMBROGNO, S., ANGELONE, T., CORTI, A., MAZZA, R., MANNARINO, C., TOTA, B. & HELLE, K. B. (2003). The inotropic influence of vasostatins on the working heart of the eel (Anguilla anguilla). Paracrine aspects and subcellular mechanisms. Proceedings of the 12th International symposium on chromaffin cell biology, 21-25 September 2003, A.
106. IGUCHI, H., CHAN, J. S., SEIDAH, N. G. & CHRETIEN, M. (1984). Tissue distribution and molecular forms of a novel pituitary protein in the rat. Neuroendocrinology 39, 453-458.
107. ISCHIA, R., HOBISCH, A., BAUER, R., WEISS, U., GASSER, R. W., HORNINGER, W., BARTSCH, G. JR., FUCHS. D., BARTCH, G., WINKLER, H., KLOCKER, H., FISCHER-COLBRIE, R. & CULIG, Z. (2000). Elevated levels of serum secretoneurin in patients with therapy resistant carcinoma of the prostate. The Journal of Urology 163, 1161-1165.
108. ISCHIA, R., LOVISETTI-SCAMIHORN, P., HOUGE-ANGELETTI, R., WOLKERSDORFER, M., WINKLER. H. & FISCHER-COLBRIE, R. (1997). Molecular cloning and characterization of NESP55, a novel chromogranin-like precursor of a peptide with 5HT 1B receptor antagonist activity. Journal of Biological Chemistry 272, 11657-11662.
109. KÄHLER, C. M. & FISCHER-COLBRIE, R. (2000). Secretoneurin - a novel link between the nervous and the immune system. Advances in Experimental Medicine and Biology 482, 279-290.
110. KÄHLER, C. M., KAUFMANN, G., KÄHLER, S. T. & WIEDERMANN, C.J. (2002a). The neuropeptide secretoneurin stimulates adhesion of human monocytes to arterial and venous endothelial cells in vitro. Regulatory Peptides 110, 65-73.
111. KÄHLER, C. M., SCHRATZBERGER, P., KAUFMANN, G., HOCHLEITNER, B., BECHTER, O., GÖTSCH, C., WÖLL, E., MARSCHANG, P., HEROLD, M. & WIEDERMANN, C. J. (2002b). Transendothelial migration of leukocytes and signalling mechanisms in response to the neuropeptide secretoneurin. Regulatory Peptides 105, 35-46.
112. KENNEDY, B. P., MAHATA, S. K. O'CONNOR, D. T. & ZIEGLER, M. G. (1998). Mechanism of cardiovascular actions of the chromogranin A fragment catestatin in vivo. Peptides 19, 1241-1248.
113. KIM, T., TAO-CHENG, J. H., EIDEN, L. E. & LOH, Y. P. (2001). Chromogranin A, an "on/off" switch controlling dense-core secretory granule biogenesis. Cell 106, 499-509.
114. KIM, T., TAO-CHENG, J. H., EIDEN, L. E. & LOH, Y. P. (2003). The role of chromogranin A and the control of secretory granule genesis and maturation. Trends in Endocrinology and Metabolism 14, 56-57.
115. KINGSLEY, D. M., RINCHIK, E. M., RUSSEL, L. B., OTTIGER, H. P., SUTCLIFFE, J. G., COPELAND, N. G. & JENKINS, N. A. (1990). Genetic ablation of a mouse gene expressed specifically in brain. EMBO Journal 9, 395-399.
116. KIRCHMAIR, R., BENZER, A., TROGER, J., MlLLER, C., MARKSTEINER, J., SARIA, A., GASSER, R. W., HOGUE-ANGELEITI, R., FISCHER-COLBRIE, R. & WINKLER, H. (1994). Molecular characterization of immunoreactivities of peptides derived from chromogranin A (GE-25) and from secretogranin II (secretoneurin) in human and bovine cerebrospinal fluid. Neuroscience 63, 11 79-1187.
117. KIRCHMAIR, R., HOGUE-ANGELETTI, R., GUTIERREZ, J., FlSCHER-COLBRIE, R. & WINKLER, H. (1993). Secretoneurin - a neuro-peptide generated in brain, adrenal medulla and other endocrine tissues by proteolytic processing of secretogranin II (chromogranin C). Neuroscience 53, 359-365.
118. KIRCHMAIR, R., LEITNER, B., FISCHER-COLBRIE, R., HOGUE-ANGELETTI, R. & WINKLER, H. (1995). Large variations in the proteolytic formation of a chromogranin A-derived peptide (GE-25) in neuroendocrine tissues. Biochemical Journal 310, 331-336.
119. KITAYAMA, N., TATEISHI, K., FUNAKOSHI, A., MIYASAKA, K. SHIMAZOE, T., KONO, A., IWAMOTO, N. & MATSUOKA, Y. (1994). Pancreastatin molecular forms in normal human plasma. Life Sciences 54, 1571-1578.
120. KLIMASCHEWSKI, L., BENNDORF, K., KIRCHMAIR, R., FISCHER-COLBRIE, R. & HEYM, C. (1995). Secretoneurin-immunoreactivity in nerve terminals opposing identified preganglionic sympathetic neurons in the rat: co-localization with substance P and enkephalin. Journal of Chemical Neuroanatomy 9, 55-63.
121. KOESLAG, J. H., SAUNDERS, P. T. & TERBLANCHE, E. (2003). A reappraisal of the blood glucose homeostat which comprehensively explains the type 2 diabetes mellitus-syndrome X complex. Journal of Physiology (Lond) 549, 333-346.
122. KOESLAG, J. H., SAUNDERS, P. T. & WESSELS, J. A. (1999). The chromogranins and counter-regulatory hormones: do they make homeostatic sense? Journal of Physiology (Lond) 517, 643-649.
123. KONECKI, D. S., BENEDUM, U. M., GERDES, H.-H. & HUTTNER, W. B. (1987). The primary structure of human chromogranin A and pancreastatin. Journal of Biological Chemistry 262, 17026-17030.
124. KRISCH, K., BUXBAUM, P., HORVAT, G., KRISCH, I., NEUHOLD, N., ULRICH, W. & SRIKANTA, S. (1986). Monoclonal antibody HISL-19 as an immunological probe for neuroendocrine differentiation. American Journal of Pathology 123, 100-108.
125. KROESEN, S., MARKSTEINER, J., LEITNER, B., HOGUE-ANGELETTI, R., FlSCHER-COLBRIE, R. & WINKLER. H. (1996). Rat brain: distribution of immunoreactivity of PE-11, a peptide derived from chromogranin B. European Journal of Neuroscience 8, 2679-2689.
126. 344-364) stimulates rat mast cell release of histamine in a manner comparable to mastoparan and other cationic charged neuropeptides. Regulatory Peptides 114, 29-35.
127. LAMANGO, N. S., APLETALINA, E., LIU, J. & LINDBERG, I. (1999). The proteolytic maturation of prohormone convertase 2 is a pH driven process. Archives of Biochemistry and Biophysics 362, 275-282.
128. LASLOP, A., DOBLINGER, A. & WEISS, U. (2000). Proteolytic processing of chromogranins. Advances in Experimental Medicine and Biology 428, 155-166.
129. LASLOP, A., WEISS, C., SAVARIA, D., EITER, C., TOOZE, S. A., SLIDAH, N. G. & WINKLER, H. (1998). Proteolytic processing of chromogranin B and secretogranin II by prohormone convertases. Journal of Neurochemistry 70, 374-383.
130. LAZURE, C., PAQUET, L., LITTHAUER, D., NAUDE, R. J., OELOFSEN, W. & CHRETIEN, M. (1990). The ostrich pituitary contains a major peptide homologous to mammalian chromogranin A (1-76). Peptides 11, 79-87.
131. LEDUC, R., HENDY, G. N., SEIDAH, N. G., CHRETIEN, M. & LAZURE, C. (1990). Fragmentation of bovine chromogranin A by plasma kallikrein. Life Sciences 46, 1427-1433.
132. LEE, R. W. H. & HUTTNER, W. B. (1983). Tyrosine-O-sulphated proteins of PC 12 pheochromocytoma cells and their sulphation by a tyrosyl protein sulfotransferase. Journal of Biological Chemistry 258, 11326-11334.
133. LEITNER, B., FISCHER-COLBRIE, R., SCHERZER, G. & WINKLER, H. (1996). Secretogranin II: relative amounts and processing to secretoneurin in various rat tissues. Journal of Neurochemistry 66, 1312-1317.
134. LEONHARDT, U. T:, STEVENSON, J. C., GHATEI, M. A., LISCHKA, A., MACDONALD, D. W., WHITEHEAD, M. I. & BLOOM, S. R. (1988). Elevated 7B2 levels during normal human pregnancy. American Journal of Obstetrics and Gynecology 158, 1141-1144.
135. LEVI, A., ELDRIDGE, J. D. & PATERSON, B. M. (1985). Molecular cloning of a gene sequence regulated by nerve growth factor. Science 229, 393-395.
136. LI, J.-Y., LOVISETTI-SCAMIHORN, P., FISCHER-COLBRIE, R., WINKLER, H. & DAHLSTRØM, A. (2002). Distribution and intraneuronal trafficking of a novel member of the chromogranin family, NESP55, in the rat peripheral nervous system. Neuroscience 110, 731-745.
137. LIANG, F., DILLEN, L., ZHANG, X. Y., COEN, E. P., HOGUE-ANGELETTI, R., CLAEYS, M. & DE POTTER, W. P. (1995). Vasostatins, N-terminal products of chromogranin A, are released from the stimulated calf spleen in vitro. Acta Physiologica Scandinavica 155, 23-30.
138. LIU, J.-W., ANDREWS, P. C., MERSHON, J. L., YAN, C., ALLEN, D. L. & BEN-JONTHAN, N. (1994). Peptide V: a VGF derived neuro-peptide purified from bovine posterior pituitary. Endocrinololgy 135, 2743-2748.
139. LOVISETTI-SCAMIHORN, P., FISCHER-COLBRIE, R., LEITNER, B., SCHERZER. G. & WINKLER. H. (1999). Relative amounts and molecular forms of NESP55 in various bovine tissues. Brain Research 829, 99-106.
140. LUGARDON, K., RAFFNER, R., GOUMON, Y., CORTI, A., DELMAS, A., BULET, P., AUNIS, D. & METZ-BOUTIGUE, M.-H. (2000). Antibacterial and antifungal activities of vasostatin-1, the N-terminal fragment of chromogranin A. Journal of Biological Chemistry 275, 10745-10753.
141. LUGARDON, K., CHASSEROT-GOLAZ, S., KIEFFER, A. E., MAGETDANA, R., NULLANS, G., KIEFFER, B., AUNIS, D. & METZ-BOUTIGUE, M.-H. (2001). Structural and biological characterization of chromofungin, the antifungal chromogranin A-(47-66)-derived peptide. Journal of Biological Chemistry 276, 35875-35882.
142. MAGET-DANA, R., METZ-BOUTIGUE, M.-H. & HELLE, K. B. (2002). The N-terminal domain of chromogrann A (CgA 1-40) interacts with monolayers of membrane lipids of fungal and mammalian compositions. Annals of the N!ew York Academy of Science 971, 352-354.
143. MAHATA, S. K., O'CONNOR, D. T., MAHATA, M., YOO, S. H., TAUPENOT, L. & Wu, H. (1997). Novel autocrine feedback control of catecholamine release. A discrete chromogranin A fragment is a noncompetitive nicotinic cholinergic antagonist. Journal of Clinical Investigations 100, 1623-1633.
144. MAHATA, S. K., MAHATA, M., PARMER, R. J. & O'CONNOR, D. T. (1999), Desensitization of catecholamine release: the novel catecholamine-release- inhibitory peptide catestatin (chromogranin A344-364) acts at the receptor to prevent nicotinic cholinergic tolerance. Journal of Biological Chemistry 274, 2920-2928.
145. MAHATA, S. K., MAHATA, M., TAYLOR, C. V. L., TAUTENOT, L., PARMER, R. J. & O'CONNOR, D. T. (2000). The novel catecholamine release inhibitory peptide catestatin (chromogranin A344-364). Properties and function. Advances in Experimental Medicine and Biology 428, 263-275.
146. MANDALÀ, M., SERCK-HANSSEN, G., MARTINO, G. & HELLE, K. B.
147. MANDALÀ, M., STRIDSBERG, M., HELLE, K. B. & SERCK-HANSSEN. G. (2000). Endothelial handling of chromogranin A. Advances in Experimental Medicine and Biology 428, 167-178.
148. MANDALÀ, M., SERCK-HANSSEN, G. & HELLE, K. B. (2003). Regulatory peptides derived from the neuroendocrine secretory protein chromogranin A. Recent Research Developments in Analytical Biochemistry 3, 155-168.
149. MARKSTEINER, J., SARIA, A., KIRCHMAIR, R., PYCHA, R., BENESCH, H., FISCHER-COLBRIE, R., HARING, C., MAIER, H. & RANSMAYR, G. (1993). Distribution of secretoneurin-like immunoreactivity in comparison with substance P- and enkephalin-like immunoreactivities in various human forebrain regions. European Journal of Neuroscience 5, 1573-1585.
150. MARKSTEINER, J., BAUER, R., KAUFMANN, W. A., WEISS, E., BARNAS, U. & MAIER, H. (1999). PE-11, a peptide derived from chromogranin B, in the human brain. Neuroscience 9, 155-1170.
151. MARTENS, G. J. (1988). Cloning and sequence analysis of human pituitary cDNA encoding the novel polypeptide 7B2. FEBS Letters 234, 160-164.
152. MARTENS, G. J., BRAKS, J. A., EIB, D. W., ZHOU, Y. & LINDBERG, I. (1994). The neuroendocrine polypeptide 7B2 is an endogenous inhibitor of prohormone convertase PC2. Proceedings of the National Academy of Science 91, 5784-5787.
153. MAZZA, R., MANNARINO, C., ANGELONE, T., CORTI, A., IMBROGNO, S. & TOTA. B. (2003). Cardiosuppressive action of vasostatins on the frog heart. Proceedings of the 12th International symposium on chromaffin cell biology, 21-25 September 2003, Abstract.
154. MBIKAY, M., SEIDAH, N. G. & CHRETIEN, M. (2001). Neuroendocrine secretory 7B2: structure, expression and functions. Biochemical Journal 357, 329-342.
155. METZ-BOUTIGUE, M.-H., GARCIA-SABLONE, P., HOGUE-ANGELETTI, R. & AUNIS, D. (1993). Intracellular and extracellularprocessing of chromogranin A. Determination of cleavage sites. European Journal of Biochemistry 217, 247-257.
156. METZ-BOUTIGUE, M.-H., GOUMON, Y., LUGARDON, K., STRUB, J. M. & AUNIS, D. (1998). Antibacterial peptides are present in chromaffin cell secretory granules. Cellular and Molecular Neurobialogy 18, 249-266.
157. METZ-BOUTIGUE, M.-H., LUGARDON, K., GOUMON, Y., RAFFNER, R., STRUB, J. M. & AUNIS, D. (2000). Antibacterial and antifungal, peptides derived from chromogranins and proenkephalin-A. Advances in Experimental Medicine and Biology 482, 299-315.
158. MILLER, C., KIRCHMAIR, R., TROGER, J., SARIA, A., FLEISCHHACKER, W. W., FISCHER-COLBRIE, R., BENZER, A. & WINKLER, H. (1996). CSF of neuroleptic-naive first-episode schizophrenic patients: levels of biogenic amines, substance P and peptides derived from chromogranin A (GE-25) and secretogranin II (secretoneurin). Biological Psychiatry 39, 911-918.
159. MISEREZ, B., ANNAERT, W., DILLEN, L., AUNIS, D. & DE POTTER, W. (1992). Chromogranin A processing in sympathetic neurons and release of chromogranin A fragments from sheep spleen. FEBS Letters 314, 122-124.
160. NATORI, S. & HUTTNER, W. B. (1996). Chromogranin B (secretogranin I) promotes sorting to the regulated pathway of processing intermediates derived from a peptide hormone precursor. Proceedings of the National Academy of Science, USA 93, 4431-4436.
161. NEUHOED, N. & ULLRICH, R. (1993). Secretogranin IV immunoreactivity in medullary thyroid carcinoma: an immunohistochemical study of 62 cases. Virchows Archives auf Pathologie, Anatomie und Hutopatkologie 42, 85-89.
162. O'CONNOR, D. T. & BERNSTEIN, K. (1984). Radioimmunoassay of chromogranin A in plasma as a measure of exocytotic sympathetoadrenal activity in normal subjects and patients with pheochromocytoma. New England Journal of Medicine 311, 764-770.
163. O'CONNOR, D. T., CERVENKA, J. H., STONE, R. A., PARMER, R. J., FRANCO-BOURLAND, R. E., MADRAZO, I. & LANGLAIS, P. J. (1993). Chromogranin A immunoreactivity in human cerebrospinal fluid: properties, relationship to noradrenergic neuronal activity and variation in neurological disease. Neuroscience 56, 999-1007.
164. O'CONNOR, D. T., KAILASAM, M. T., KENNEDY, B. P., ZIEGLER, M. G., YANAIHARA, N. & PARMER, R. J. (2002). Early decline in the catecholamine release-inhibitory peptide catestatin in humans at genetic risk of hypertension. Journal of Hypertension 20, 1335-1345.
165. OTTIGER, H. P., BATTENBERG, E. F., TSOU, A. P., BLOOM, F. E. & SUDCLIFFE, J. G. (1990). 1B1075: a brain- and pituitary-specific mRNA that encodes a novel chromogranin/secretogranin-like component of intracellular vesicles. Journal of Neuroscience 10, 3135-3147.
166. OULYADI, H., DAVOUST, D. & VAUDRY, H. (1997). A determination of the solution conformation of secretoneurin, a neuropeptide originating from the processing of secretogranin II, by IH-NMR and restrained molecular dynamics. European Journal of Biochemistry 246, 665-673.
167. OZAWA, H. & TAKATA, K. (1995). The granin family - its role in sorting and secretory granule formation. Cell Structure and Function 20, 415-420.
168. PAQUET, L., BERGERON, F., BOUDREAULT, A., SEIDA, N. G., CHRETIEN, M., MBIKAY, M. & LAZURE, C. (1994). The neuroendocrine precursor 7B2 is a sulphated protein proteolytically processed by a ubiquitous furin-like convertase. Journal of Biological Chemistry 269, 19279-19285.
169. PARMER, R.J., XI, X.-P., WU, H.-J., HELMAN, L. J. & PETZ, L. N. (1993). Secretory protein traffic. Chromogranin A contains a dominant targeting signal for the regulated pathway. Journal of Clinical Investigations 92, 1042-1054.
170. PARMER, R. J., MAHATA, S. K., JIANG, O., TAUPENOT, L., GONG, Y., MAHATA, M., O'CONNOR, D. T. & MILES, L. A. (2000). Tissue plasminogen activator and chromaffin cell function. Advances in Experimental Medicine and Biology 428, 179-191.
171. PETERSON, J. B., NELSON, D. L., LING, E. & ANGELETTI, R. H. (1987). Chromogranin A-like proteins in the secretory granules of a protozoan, Paramecium tetraurelia. Journal of Biological Chemistry 262, 17264-17267.
172. PHILLIPS, J. H., ALLISON, Y. P. & MOVIS, S. (1977). The distribution of calcium, magnesium, copper and iron in the bovine adrenal medulla. Neuroscience 2, 147-152.
173. PIMLIKAR, S. W. & HUTTNER, W. B. (1992). Chromogranin B (secretogranin I), a secretory protein of the regulated pathway, is also present in a tightly membrane-associated form in PC 12 cells. Journal of Biological Chemistry 267, 4110-4118.
174. POHL, T. M., PHILLIPS, E., SONG, K., GERDES, H.-H., HUTTNER, W. B. & RUTHER. U. (1990). The organisation of the mouse chromogranin B (secretogranin I) gene. FEBS Letters 262, 219-224.
175. PORTELA-GOMES, G. M. & STRIDSBERG, M. (2001). Selective processing of chromogranin A in the different islet cells in human pancreas. Journal of Histochemistry and Cytochemistry 49, 483-490.
176. PORTELA-GOMES, G. M. & STRIDSBERG, M. (2002a). Region-specific antibodies to chromogranin B display various immunostaining patterns in human endocrine pancreas. Journal of Histochemistry and Cytochemistry 50, 1023-1030.
177. PORTELA-GOMES, G. M. & STRIDSBERG, M. (2002b). Chromogranin in the human gastrointestinal tract: an immunocytochemical study with region-specific antibodies. Journal of Histochemistry and Cytochemistry 50, 1487-1492.
178. RATTI, S., CURNIS, F., LONGHI, R., COLOMBO, B., GASPARRI, A., MAGNI, F., MANERA, E., METZ-BOUTIGUE, M. H. & CORTI, A. (2000). Structure-activity relationships of chromogranin A in cell adhesion. Identification of an adhesion site for fibroblasts and smooth muscle cells. Journal of Biological Chemistry 275, 29257-29263.
179. REINECKE, M., HÖÖG, A., ÖSTENSON, C.-G., EFENDIC, S., GRIMELIUS, L. & FALKMER, S. (1991). Phylogenetic aspects of pancreastatin- and chromogranin-like immunoreactive cells in the gastro-entero-pancreatic neuroendocrine system of vertebrates. General and Comparative Endocrinology 83, 167-182.
180. REINICH, N., KIRCHMAIR, R., KÄHLER, C. M., HOGUE-ANGELETTI, R., FISCHER-COLBRIE, R. & WINKLER, H. (1993). Attraction of human monocytes by the neuropeptide secretoneurin. FEBS Letters 334, 41-44.
181. RIEKER, S., FISCHER-COLBRIE, R., EIDEN, L. & WINKLER, H. (1988). Phylogenetic distribution of peptides related to chromogranins A and B. Journal of Neurochemistry 50, 1066-1073.
182. ROSA, P. & ZANINI, A. (1983). Purification of a sulphated secretory protein from the adenohypophysis. Immunochemical evidence that similar macromolecules are present in other glands. European Journal of Cellular Biology 31, 94-98.
183. ROSA, P., HILLE, A., LEE, R. W., ZANIM, A., DE CAMILLI, P. & HUTTNER, W. B. (1985). Secretogranins I and II: two tyrosine-sulphated secretory proteins common to a variety of cells secreting peptides by the regulated pathway. Journal of Cellular Biology 101, 1999-2011.
184. RUSSELL, J., GEE, P., LIU, S. M. & ANGELETTI, R. H. (1994). Stimulation of parathyroid hormone secretion by low calcium is inhibited by amino terminal chromogranin peptides. Endocrinology 135, 337-342.
185. SAKAI, Y., HOSAKA, M., HIRA, Y., HRUMI, T., OHSAWA, Y., WANG, H., TAKEUCHI, T., UCHIYAMA, Y. & WATANABE, T. (2003). Immunocytochemical localization of secretogranin III in the anterior lobe of the male rat pituitary glands. Journal of Histochemistry and Cytochemistry 51, 227-238.
186. SALTON. S. R. J., FERRI, G.-L., HAHM, S., SNYDER, S. E., WILSON, A. J., POSSENTI, R. & LEVI, A. (2000). VFG: a novel role for this neuronal and neuroedocrine polypeptide in the regulation of energy balance. Frontiers in Neuroendocrinology 21, 199-219.
187. SALZET, M. & VERGER-BOCQUET, M. (2002). Cellular localization of chromogranin B-like derived peptides in leeches. Neuroendocrinology Letters 23, 209-212.
188. SARIA, A., TROGER, J., KIRCHMAIR, R., FISCHER-COLBRIE, R., HOGUE-ANGELETTI, R. & WINKLER. H. (1993). Secretoneurin releases dopamine from rat striatal slices: a biological effect of a peptide derived from secretogranin II (chromogranin C). Neuroscience 54, 1-4.
189. SANCHEZ-MARGALET, V. & GOBERNA, R. (1994). Pancreastatin inhibits insulin-stimulated glycogen synthesis but not glycolysis in rat hepatocytes. Regulatory Peptides 51, 215-220.
190. SANCHEZ-MARGALET, V., GONZALEZ-YANES, C., SANTOS-ALVAREZ, J. & NAJIB. S. (2000). Pancreastatin. Biological effects and mechanisms of action. Advances in Experimental Medicine and Biology 428, 247-262.
191. SCHAFER, M. K., NOHR, D., ROMEO, H., EIDEN, E. E. & WEIHE, E. (1994). Pan-neuronal expression of chromogranin A in rat nervous system. Peptides 15, 263-279.
192. SCHIMMEL, A., BRAÜNLING, O., RÜTHER, U., HUTTNER, W. B. & GERDES, H.-H. (1992). The organisation of the mouse secretogranin II gene. FEBS Letters 314, 375-380.
193. SCHMID, K. W., KUNK, B., KIRCHAMAIR, R., TOTSCH, M., BOCKER, W. & FISCHER-COLBRIE, R. (1995). Immunohistochemical detection of secretoneurin, a novel neuropeptide endoproteolytically processed from secretogranin II, in normal human endocrine and neuronal tissues. Histochemical Journal 27, 473-481.
194. SCHMIDT, W.E. & CREUTZFELDT, W. (1991). Pancreastatin - a novel regulatory peptide? Acta Oncologica 30, 441-449.
195. SEIDAH, N. G., HSI, K. L., DE SERRES, G., ROCHEMONT, J., HAMELN, J., ANTAKLY, T., CANTIN, M. & CHRETIEN, M. (1983). Isolation and NH2-terminal sequence of a highly conserved human and porcine pituitary protein belonging to a new super-family. Immunocytochemical localization in pars distalis and pars nervosa of the pituitary and in the supraoptic nucleus of the hypothalamus. Archives of Biochemistry and Biophysics 225, 525-534.
196. SEIDAH, N. G. & CHRETIEN, M. (1999). Proprotein and prohormone convertases: a family of subtilases generating diverse bioactive polypeptides. Brain Research 848, 45-62.
197. SEIDAH, N. G., DONG, W., SAVARIA, D., ZHENG, M., PINTAR, J. E. & DAY, R. (1998). Neuroendocrine protein 7B2 is essential for proteolytic conversion and activation of proprotein convertase 2 in vivo. DNA Cellular Biology 17, 1017-1029.
198. SIEGEL, E. G., GALLWITZ, B., FÖLSCH, U. R. & SCHMIDT, W. E. (1998). Effect of human pancreastatin peptide (hP-16) on oral glucose tolerance in man. Experimental and Clinical Endocrinology and Diabetes 106, 178-182.
199. SIMON, J. P. & AUXIS, D. (1989). Biochemistry of the chromogranin A protein family. Biochemical Journal 262, 1-13.
200. SMITH, W. J. & KIRSHNER, N. (1967). A specific soluble protein from the catecholamine storage vesicles of bovine adrenal medulla. Purification and chemical characterization. Molecular Pharmacology 3, 52-62.
201. SMITH, A. D. & WINKLER, H. (1967). Purification and properties of an acidic protein from chromaffin granules of bovine adrenal medulla. Biochemical Journal 103, 483-492.
202. SRIKANTA, S., KRISCH, K. & EISENBARTH, G. (1986). Novel islet proteins defined by islet cell antibody HISL-19. Diabetes 35, 300-305.
203. STARK, M., DANIELSSON, O., GRIFFITH, W. J., JÖRNYALL, H. & JOHANSSON, J. (2001). Peptide repertoire of human cerebrospinal fluid: novel proteolytic fragments of neuroendocrine proteins. Journal of Chromatography B 754, 357-367.
204. STRIDSBERG, M., ANGELETTI, R. H. & HELLE, K. B. (2000). Characterization of N-terminal chromogranin A and chromogranin B in mammals by region-specific radioimmunoassays and Chromatographic separation methods. Journal of Endocrinology 165, 703-714.
205. STRIDSBERG, M., ERIKSSON, B., ÖBERG, K. & JANSON, E. T. (2003). A comparison between three commercial kits for chromogranin A measurements. Journal of Endocrinology 177, 337-341.
206. STRIDSBERG, M., ÖBERG. K., LI, Q., EGSTRÖM, U. & LUNDQUIST, G. (1995). Measurements of chromogranin A, chromogranin B (secretogranin I), chromogranin C (secretogranin II) and pancreastatin in plasma and urine from patients with carcinoid tumours and endocrine pancreatic tumours. Journal of Endocrinology 144, 49-59.
207. STRUB, J. M., GARCIA-SABLONE, P., LØNNING. K., TAUPENOT, L., HUBERT, P., VAN DORSSELAER, A., AUNIS, D. & METZ-BOUTIGUE, M.-H. (1995). Processing of chromogranin B in bovine adenal medulla. Identification of secretolytin, the endogenous C-terminal fragment of residues 614-626 with antibacterial activity. European Journal of Biochemistry 22, 356-368.
208. STRUB, J. M., GOUMON, Y., LUGARDON, K., CAPON, C., LOPEZ, M., MONIATTE, M., VAN DORSSELAER, A., AUNIS, D. & METZ-BOUTIGUE, M. H. (1996a). Antibacterial activity of glycosylated and phosphorylated chromogranin A-derived peptide 173-194 from bovine adrenal medullary chromaffin granules. Journal of Biological Chemistry 271, 28533-28540.
209. STRUB, J. M., HUBERT, P., NULLANS, G., AUNIS, D. & METZ-BOUTIGUE, M.-H. (1996b). Antibacterial activity of secretolytin, a chromogranin B-derived peptide (614-626), is correlated with peptide structure. FEBS Letters 379, 273-278.
210. STRUB, J. M., SOROKINE, O., VAN DORSSELAER, A., AUNIS, D. & METZ-BOUTIQUE, M.-H. (1997). Phosphorylation and O-glycosylation of bovine chromogranin A from adrenal medullary chromaffin granules and their relationship with biological activities. Journal of Biological Chemistry 272, 11928-11936.
211. SUZURI, H., SATO, S., SUZUKI, Y., OTHAKE, R., HASHIGAMI, Y., NAMBA, J., ISHIHARA, N. & SHIMODA. A. (1989). Pituitary 7B2-like protein in cerebrospinal fluid: comparison with other neuropeptides. Journal of Laboratory and Clinical Medicine 113, 743-748.
212. TATEMOTO, K., EFENDIC, S., MUTT, V., MAKK, G., FEISTNER, G. J. & BARCHAS, J. D. (1986). Pancreastatin, a novel pancreatic peptide that inhibits insulin secretion. Nature (Lond) 324, 476-478.
213. TAUPENOT, L., CIESIELSKI-TRESKA, J., ULRICH, G., CHASSEROT-GOLAZ, S., AUNIS, D. & BADER, M. F. (1996). Chromogranin A triggers a phenotypic transformation and the generation of nitric oxide in brain microglial cells. Neuroscience 72, 377-389.
214. TAUPENOT, L., HARPER, K. L., MAHAPATRA, N. R., PARMER, R. J., MAHATA, S. K. & O'CONNOR, D. T. (2002). Identification of a novel sorting determinant for the regulated pathway in the secretory protein chromogranin A. Journal of Cell Science 115, 4827-4841.
215. TAUPENOT, L., HARPER, K. L. & O'CONNOR, D. T. (2003). Mechanisms of disease: the chromogranin-secretogranin family. The New England Journal of Medicine 348, 1134-1149.
216. THIELE, C. & HUTTNER, W. B. (1998). The disulfide-bonded loop of chromogranins, which is essential for sorting to secretory granules, mediates homodimerization. Journal of Biological Chemistry 273, 1223-1231.
217. TOOZE, S. A. (1998). Biogenesis of secretory granules in the trans-Golgi network of neuroendocrine and endocrine cells. Biochimica Biophysica Acta 1404, 231-244.
218. TOOZE, S. A., FLATMARK, T., TOOZE, J. & HUTTNER, W. B. (1991). Characterization of the immature secretory granule, an intermediate in granule biogenesis. Journal of Cellular Biology 115, 1491-1503.
219. TOTA, B., MAZZA, R., ANGELONE, A., NULLANS, G., METZ-BOUTIGUE, M-H., AUNIS, D. & HELLE, K. B. (2003). Peptides from the N-terminal domain of Chromogranin A (Vasostatins) exert negative inotropic effects in the isolated frog heart. Regulatory Peptides 114, 123-130.
220. TRANI, E., COTTI, T., RINALDI, A. M., CANU, N., FERRI, G. I., LEVI, A. & POSSEXTI, R. (1995). Tissue-specific processing of the neuroendocrine protein VGF. Journal of Neurochemistry 65, 2441-2449.
221. TRANI, E., GIORGI, A., CANU, N., AMADORO, G., RINALDI, A. M., HALBAN, P. A., FERRI, G. L., POSSENTI, R., SCHININA, M. E. & LEVI, A. (2002). Isolation and characterization of VGF peptides in rat brain. Role of PC 1/3 and PC 2 in the maturation of VGF precursor. Journal of Neurochemistry 81, 565-574.
222. TSIGELNY, I., MAHATA, S. K., TAUPENOT, L., PREECE, N. E., MAHATA, M., KAHN, I., PARMER, R. J. & O'CONNOR, D. T. (1998). Mechanism of action of chromogranin A on catecholamine release: molecular modeling of the catestatin region reveals a β-strand/loop/β-strand structure secured by hydrophobic interactions and predictive of activity. Regulatory Peptides 77, 43-53.
223. TURQUIER, V., VAUDRY, H., JEGOUS, S. & ANOUAR, Y. (1999). Frog chromogranin A messenger ribonucleic acid encodes three highly conserved peptides. Coordinate regulation of proopiomelanocortin and chromogranin A expression in the pars intermedia of the pituitary during color adaptation. Endocrinology 140, 4104-4112.
224. VAN HORSSEN, A. M., VAN KUPPEVELD, F. J. & MARTENS, G. J. (1996). Manipulation of disulfide bonds differentially affects the intracellular transport, sorting and processing of neuroendocrine secretory proteins. Journal of Neurochemistry 71, 402-409.
225. VAUDRY, H. & CONLON, J. M. (1991). Identification of a peptide arising from the specific post-translation processing of secretogranin II. FEBS Letters 284, 31-33.
226. WATKINSON, A., JONSSON, A.C., DAVIDSON, M., YOUNG, J., LEE, C. M., MOORE, S. & DOCKREY, G. (1991). Heterogeneity of chromogranin A-derived peptides in bovine gut, pancreas and adrenal medulla. Biochemical Journal 276, 471-479.
227. WATKINSON, A., ROGERS, M. & DOCKREY, G. (1993). Post-translational processing of chromogranin A: differential distribution of phosphorylated variants of pancreastatin and fragments 248-313 and 297-313 in bovine pancreas and ileum. Biochemical Journal 295, 649-654.
228. WIEDERMANN, C. J. (2000). Secretoneurin: a functional neuropeptide in health and disease. Peptides 21, 1289-1298.
229. WEISS, U. R., ISCHIA, R., EDER, S., LOWTSETTI-SCAMIHORN, P., BAUER, R. & FISCHER-COLBRIE, R. (2000). Neuroendocrine secretory protein 55 (NESP55): alternative splicing into transcripts of the GNAS gene and posttranslational processing of a maternally expressed protein. Neuroendocrinolology 71, 177-186.
230. WINKLER, H. & FISCHER-COLBRIE, R. (1992). The chromogranins A and B: the first 25 years and future perspectives. Neuroscience 49, 497-528.
231. WOHLFARTER, T., FISCHER-COLBRIE, R., ANGELETTI, R. H., EIDEN, L. E. & WINKLER, H. (1989). Processing of chromogranin A within chromaffin granules starts at C- and N-terminal cleavage sites. FIBS Letters 231, 67-70.
232. WU, H. J., ROZANSKY, D. J., PARMER, R. J., GILL, B. M. & O'CONNOR, D. T. (1991). Structure and function of the chromogranin A gene. Journal of Biological Chemistry 266, 13130-13134.
233. YANAIHARA, N., NISHIKAWA, Y., HOSHINO, M., MOCHIZUKI, T., IGUCHI, K., NAGASAWA, S., JUN, L., FUTAI, Y., KANNO, T., YANAIHARA, H., MURAI, M. & YANAIHARA, C. (1998). Evaluation of region-specific radioimmunoassays for rat and human chromogranin A: measurement of immunoreactivity in plasma, urine and saliva. In The Adrenal Cell (eds. T. Kanno, Y. Nakazato and K. Kumakura), pp. 305-313. Hokkaido University Press, Sapporo, Japan.
234. 2+ -dependent calmodulin-binding region of chromogranin A. Biochemistry 31, 6134-6140.
235. YOO, S. H. (1993). pH-dependent association of chromogranin A with secretory vesicle membrane and a putative membrane binding region of chromogranin A. Biochemistry 32, 8213-8219.
236. YOU, Z. B., SARIA, A., FISCHER-COLBRIE, R., TERENIUS, L., GOINY, M. & HERRERA-MARSCHITZ, M. (1996). Effects of secretogranin II-derived peptides on the release of neurotransmitters monitored in the basal ganglia of the rat with in vivo microdialysis. Naunyn Schmiedebergs Archives für Pharmacologie 354, 717-724.
237. ZHANG, X., DILLEN, L., BAUER. S. H. J., VAN DONGEN, W., LIANG, F., PRZBYLSKI, M., ESMAN, E., DE POTTER, W. P. & CLAEYS, M. (1997). Mass spectrometric identification of phosphorylated vasostatin II, a chromogranin A-derived fragment 1-113. Biochimica et Biophysica Acta 1343, 287-298.